BRYN DESANTIS: Open Payments
NPI 1043591233 · WESTLAKE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$974 in 51 payments from 10 companies in 2025. Trend: 2023 $540 · 2024 $819 · 2025 $974
Food & beverage: $974
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $421 |
| GENZYME CORPORATION | 5 | $97 |
| Ardelyx, Inc. | 5 | $90 |
| QOL Medical, LLC | 4 | $76 |
| Aimmune Therapeutics, Inc. | 3 | $76 |
| Madrigal Pharmaceuticals | 3 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $49 |
| Regeneron Healthcare Solutions, Inc. | 3 | $46 |
| Lilly USA, LLC | 2 | $40 |
| Ipsen Biopharmaceuticals, Inc | 1 | $23 |
Products named: RINVOQ, DUPIXENT, IBSRELA, Sucraid, VOWST, LINZESS, REZDIFFRA, ENTYVIO.
Industry payments across OH — which companies pay providers there.
